Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Loss of imprinting of IGF2 characterises high IGF2 mRNA-expressing type of fibroblast-like synoviocytes in rheumatoid arthritis.

Martin-Trujillo A, van Rietschoten JG, Timmer TC, Rodríguez FM, Huizinga TW, Tak PP, Marsal S, Ibrahim SM, Dijkmans BA, van der Pouw Kraan TC, Verweij CL.

Ann Rheum Dis. 2010 Jun;69(6):1239-42. doi: 10.1136/ard.2008.106195. Epub 2009 Jun 24.

PMID:
19556211
2.

Epigenetic regulation and nucleosome positioning in the human TATA-less IL-1 alpha promoter.

van Rietschoten JG, Gal-Yam EN, Jeong S, Cortez CC, Verweij CL, Jones PA.

Genes Immun. 2008 Oct;9(7):582-90. doi: 10.1038/gene.2008.53. Epub 2008 Jul 10.

PMID:
18615092
3.

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis.

Henken FE, Wilting SM, Overmeer RM, van Rietschoten JG, Nygren AO, Errami A, Schouten JP, Meijer CJ, Snijders PJ, Steenbergen RD.

Br J Cancer. 2007 Nov 19;97(10):1457-64. Epub 2007 Oct 30.

4.

Differentially methylated alleles in a distinct region of the human interleukin-1alpha promoter are associated with allele-specific expression of IL-1alpha in CD4+ T cells.

van Rietschoten JG, Verzijlbergen KF, Gringhuis SI, van der Pouw Kraan TC, Bayley JP, Wierenga EA, Jones PA, Kooter JM, Verweij CL.

Blood. 2006 Oct 1;108(7):2143-9. Epub 2006 Jun 20.

5.

First chemical synthesis of a scorpion alpha-toxin affecting sodium channels: the Aah I toxin of Androctonus australis hector.

M'Barek S, Fajloun Z, Cestèle S, Devaux C, Mansuelle P, Mosbah A, Jouirou B, Mantegazza M, Van Rietschoten J, El Ayeb M, Rochat H, Sabatier JM, Sampieri F.

J Pept Sci. 2004 Nov;10(11):666-77.

PMID:
15568681
6.

A novel polymorphic GATA site in the human IL-12Rbeta2 promoter region affects transcriptional activity.

van Rietschoten JG, Westland R, van den Bogaard R, Nieste-Otter MA, van Veen A, Jonkers RE, van der Pouw Kraan TC, den Hartog MT, Wierenga EA.

Tissue Antigens. 2004 Jun;63(6):538-46.

PMID:
15140029
7.

Activation of the STAT1 pathway in rheumatoid arthritis.

Kasperkovitz PV, Verbeet NL, Smeets TJ, van Rietschoten JG, Kraan MC, van der Pouw Kraan TC, Tak PP, Verweij CL.

Ann Rheum Dis. 2004 Mar;63(3):233-9.

8.

Cobatoxin 1 from Centruroides noxius scorpion venom: chemical synthesis, three-dimensional structure in solution, pharmacology and docking on K+ channels.

Jouirou B, Mosbah A, Visan V, Grissmer S, M'Barek S, Fajloun Z, Van Rietschoten J, Devaux C, Rochat H, Lippens G, El Ayeb M, De Waard M, Mabrouk K, Sabatier JM.

Biochem J. 2004 Jan 1;377(Pt 1):37-49.

9.

Allele-specific expression of the IL-1 alpha gene in human CD4+ T cell clones.

Bayley JP, van Rietschoten JG, Bakker AM, van Baarsen L, Kaijzel EL, Wierenga EA, van der Pouw Kraan TC, Huizinga TW, Verweij CL.

J Immunol. 2003 Sep 1;171(5):2349-53.

10.

Liposomal encapsulation enhances antiviral efficacy of SPC3 against human immunodeficiency virus type-1 infection in human lymphocytes.

de Mareuil J, Mabrouk K, Doria E, Moulard M, de Chasteigner S, Oughideni R, van Rietschoten J, Rochat H, De Waard M, Sabatier JM.

Antiviral Res. 2002 Jun;54(3):175-88.

PMID:
12062390
11.

Silencer activity of NFATc2 in the interleukin-12 receptor beta 2 proximal promoter in human T helper cells.

van Rietschoten JG, Smits HH, van de Wetering D, Westland R, Verweij CL, den Hartog MT, Wierenga EA.

J Biol Chem. 2001 Sep 14;276(37):34509-16. Epub 2001 Jul 3.

12.

IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression.

Smits HH, van Rietschoten JG, Hilkens CM, Sayilir R, Stiekema F, Kapsenberg ML, Wierenga EA.

Eur J Immunol. 2001 Apr;31(4):1055-65.

13.

TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation.

Pype S, Declercq W, Ibrahimi A, Michiels C, Van Rietschoten JG, Dewulf N, de Boer M, Vandenabeele P, Huylebroeck D, Remacle JE.

J Biol Chem. 2000 Jun 16;275(24):18586-93.

14.

Genomic organization of the human interleukin-12 receptor beta2-chain gene.

van Rietschoten JG, Smits HH, Westland R, Verweij CL, den Hartog MT, Wierenga EA.

Immunogenetics. 2000 Jan;51(1):30-6.

PMID:
10663559
15.

Chemical synthesis and structure-activity relationships of Ts kappa, a novel scorpion toxin acting on apamin-sensitive SK channel.

Lecomte C, Ferrat G, Fajloun Z, Van Rietschoten J, Rochat H, Martin-Eauclaire MF, Darbon H, Sabatier JM.

J Pept Res. 1999 Nov;54(5):369-76.

PMID:
10563502
16.

V3 loop-derived peptide SPC3 inhibits infection of CD4- and galactosylceramide- cells by LAV-2/B.

Moulard M, Mabrouk K, Martin I, Van Rietschoten J, Rochat H, Sabatier JM.

J Pept Res. 1999 Jun;53(6):647-55.

PMID:
10408339
17.

Anti-platelet activity of the peptides composing the lebetin 1 family, a new class of inhibitors of platelet aggregation.

Barbouche R, Marrakchi N, Mabrouk K, Krifi MN, Van Rietschoten J, Fenouillet E, El Ayeb M, Rochat H.

Toxicon. 1998 Dec;36(12):1939-47.

PMID:
9839678
18.

Maurotoxin, a four disulfide bridges scorpion toxin acting on K+ channels.

Rochat H, Kharrat R, Sabatier JM, Mansuelle P, Crest M, Martin-Eauclaire MF, Sampieri F, Oughideni R, Mabrouk K, Jacquet G, Van Rietschoten J, El Ayeb M.

Toxicon. 1998 Nov;36(11):1609-11.

PMID:
9792177
19.

Targeting of CFTR protein is linked to the polarization of human pancreatic duct cells in culture.

Hollande E, Fanjul M, Chemin-Thomas C, Devaux C, Demolombe S, Van Rietschoten J, Guy-Crotte O, Figarella C.

Eur J Cell Biol. 1998 Jul;76(3):220-7.

PMID:
9716269
20.

Synthetic peptides as tools to investigate the structure and pharmacology of potassium channel-acting short-chain scorpion toxins.

Lecomte C, Sabatier JM, Van Rietschoten J, Rochat H.

Biochimie. 1998 Feb;80(2):151-4. Review.

PMID:
9587672
21.

Solution structure of maurotoxin, a scorpion toxin from Scorpio maurus, with high affinity for voltage-gated potassium channels.

Blanc E, Sabatier JM, Kharrat R, Meunier S, el Ayeb M, Van Rietschoten J, Darbon H.

Proteins. 1997 Nov;29(3):321-33.

PMID:
9365987
22.

3D structure of kaliotoxin: is residue 34 a key for channel selectivity?

Gairí M, Romi R, Fernández I, Rochat H, Martin-Eauclaire MF, Van Rietschoten J, Pons M, Giralt E.

J Pept Sci. 1997 Jul-Aug;3(4):314-9.

PMID:
9262650
23.

Maurotoxin, a four disulfide bridge toxin from Scorpio maurus venom: purification, structure and action on potassium channels.

Kharrat R, Mansuelle P, Sampieri F, Crest M, Oughideni R, Van Rietschoten J, Martin-Eauclaire MF, Rochat H, El Ayeb M.

FEBS Lett. 1997 Apr 14;406(3):284-90.

24.

In vivo protection against Androctonus australis hector scorpion toxin and venom by immunization with a synthetic analog of toxin II.

Zenouaki I, Kharrat R, Sabatier JM, Devaux C, Karoui H, Van Rietschoten J, el Ayeb M, Rochat H.

Vaccine. 1997 Feb;15(2):187-94.

PMID:
9066037
25.

Chemical synthesis and characterization of maurotoxin, a short scorpion toxin with four disulfide bridges that acts on K+ channels.

Kharrat R, Mabrouk K, Crest M, Darbon H, Oughideni R, Martin-Eauclaire MF, Jacquet G, el Ayeb M, Van Rietschoten J, Rochat H, Sabatier JM.

Eur J Biochem. 1996 Dec 15;242(3):491-8.

26.

Characterization of PO1, a new peptide ligand of the apamin-sensitive Ca2+ activated K+ channel.

Zerrouk H, Laraba-Djebari F, Fremont V, Meki A, Darbon H, Mansuelle P, Oughideni R, van Rietschoten J, Rochat H, Martin-Eauclaire MF.

Int J Pept Protein Res. 1996 Dec;48(6):514-21.

PMID:
8985784
27.
28.

Synthesis and characterization of leiurotoxin I analogs lacking one disulfide bridge: evidence that disulfide pairing 3-21 is not required for full toxin activity.

Sabatier JM, Lecomte C, Mabrouk K, Darbon H, Oughideni R, Canarelli S, Rochat H, Martin-Eauclaire MF, van Rietschoten J.

Biochemistry. 1996 Aug 20;35(33):10641-7.

PMID:
8718853
29.

Solution structure of P01, a natural scorpion peptide structurally analogous to scorpion toxins specific for apamin-sensitive potassium channel.

Blanc E, Fremont V, Sizun P, Meunier S, Van Rietschoten J, Thevand A, Bernassau JM, Darbon H.

Proteins. 1996 Mar;24(3):359-69.

PMID:
8778783
30.

Recombinant and chemical derivatives of apamin. Implication of post-transcriptional C-terminal amidation of apamin in biological activity.

Devaux C, Knibiehler M, Defendini ML, Mabrouk K, Rochat H, Van Rietschoten J, Baty D, Granier C.

Eur J Biochem. 1995 Aug 1;231(3):544-50.

31.

Correlation of antiviral activity with beta-turn types for V3 synthetic multibranched peptides from HIV-1 gp120.

Mabrouk K, Van Rietschoten J, Rochat H, Loret EP.

Biochemistry. 1995 Jul 4;34(26):8294-8.

PMID:
7599121
32.

SPC3, a nontoxic peptide inhibitor of HIV infection.

Sabatier JM, Baghdiguian S, Yahi N, Rochat H, Van Rietschoten J, Fantini J.

In Vitro Cell Dev Biol Anim. 1995 Jun;31(6):415-8. No abstract available.

PMID:
8589880
33.

SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms.

Yahi N, Fantini J, Baghdiguian S, Mabrouk K, Tamalet C, Rochat H, Van Rietschoten J, Sabatier JM.

Proc Natl Acad Sci U S A. 1995 May 23;92(11):4867-71.

34.

Characterization of an electrogenic sodium/glucose cotransporter in a human colon epithelial cell line.

Delezay O, Verrier B, Mabrouk K, van Rietschoten J, Fantini J, Mauchamp J, Gerard C.

J Cell Physiol. 1995 Apr;163(1):120-8.

PMID:
7896888
35.

A new conotoxin affecting sodium current inactivation interacts with the delta-conotoxin receptor site.

Fainzilber M, Lodder JC, Kits KS, Kofman O, Vinnitsky I, Van Rietschoten J, Zlotkin E, Gordon D.

J Biol Chem. 1995 Jan 20;270(3):1123-9.

36.

The kaliotoxin family enlarged. Purification, characterization, and precursor nucleotide sequence of KTX2 from Androctonus australis venom.

Laraba-Djebari F, Legros C, Crest M, Céard B, Romi R, Mansuelle P, Jacquet G, van Rietschoten J, Gola M, Rochat H, et al.

J Biol Chem. 1994 Dec 30;269(52):32835-43.

37.

Kaliotoxin (1-37) shows structural differences with related potassium channel blockers.

Fernández I, Romi R, Szendeffy S, Martin-Eauclaire MF, Rochat H, Van Rietschoten J, Pons M, Giralt E.

Biochemistry. 1994 Nov 29;33(47):14256-63.

PMID:
7524673
38.

Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages.

Yahi N, Fantini J, Mabrouk K, Tamalet C, de Micco P, van Rietschoten J, Rochat H, Sabatier JM.

J Virol. 1994 Sep;68(9):5714-20.

39.

[Preparation of antivenins to scorpion venoms and a protection trials in animal models].

Kharrat R, Zenouaki I, Sabatier JM, Belasfar Z, Miled K, Karoui H, Van Rietschoten J, Dellagi K, Rochat H, el Ayeb M.

Arch Inst Pasteur Tunis. 1994 Jul-Oct;71(3-4):473-6. French. No abstract available.

PMID:
8801846
40.
41.

Leiurotoxin I, a scorpion toxin specific for Ca(2+)-activated K+ channels. Structure-activity analysis using synthetic analogs.

Sabatier JM, Fremont V, Mabrouk K, Crest M, Darbon H, Rochat H, Van Rietschoten J, Martin-Eauclaire MF.

Int J Pept Protein Res. 1994 May;43(5):486-95.

PMID:
8070973
42.

Solution structure of P05-NH2, a scorpion toxin analog with high affinity for the apamin-sensitive potassium channel.

Meunier S, Bernassau JM, Sabatier JM, Martin-Eauclaire MF, Van Rietschoten J, Cambillau C, Darbon H.

Biochemistry. 1993 Nov 16;32(45):11969-76.

PMID:
8218272
43.

Multi-branched peptides based on the HIV-1 V3 loop consensus motif inhibit HIV-1 and HIV-2 infection in CD4+ and CD4- cells.

Fantini J, Yahi N, Mabrouk K, Van Rietschoten J, Rochat H, Sabatier JM.

C R Acad Sci III. 1993 Nov;316(11):1381-7.

PMID:
7916261
44.

Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid.

Tordjeman M, Fontan G, Rabillon V, Martin J, Trepo C, Hoffenbach A, Mabrouk K, Sabatier JM, Van Rietschoten J, Somme G.

J Med Virol. 1993 Nov;41(3):221-9.

PMID:
7505307
45.

Evaluation of structure-antigenicity relationship of peptides from human immunodeficiency virus type 1 (HIV-1) p18 protein by circular dichroism.

Mabrouk K, Moulard M, Gluckman JC, Romi R, Rochat H, Van Rietschoten J, Bahraoui E.

Mol Immunol. 1993 Apr;30(5):503-12.

PMID:
8464430
46.

P05, a new leiurotoxin I-like scorpion toxin: synthesis and structure-activity relationships of the alpha-amidated analog, a ligand of Ca(2+)-activated K+ channels with increased affinity.

Sabatier JM, Zerrouk H, Darbon H, Mabrouk K, Benslimane A, Rochat H, Martin-Eauclaire MF, Van Rietschoten J.

Biochemistry. 1993 Mar 23;32(11):2763-70.

PMID:
8457543
47.

Cytotoxic effect on lymphocytes of Tat from human immunodeficiency virus (HIV-1).

Benjouad A, Mabrouk K, Moulard M, Gluckman JC, Rochat H, Van Rietschoten J, Sabatier JM.

FEBS Lett. 1993 Mar 15;319(1-2):119-24.

48.

Specificity of anti-P25 antibodies produced against whole HIV-1 particles or soluble forms of the protein.

Mabrouk K, Benjouad A, Gluckman JC, Rochat H, Van Rietschoten J, Bahraoui E.

Mol Immunol. 1992 Nov;29(11):1309-18.

PMID:
1406719
49.

Specificity of anti-peptide antibodies elicited against synthetic peptides mimicking conserved regions of HIV1 envelope glycoprotein.

Clerget-Raslain B, Benjouad A, van Rietschoten J, Montagnier L, Rochat H, Bahraoui E.

Res Virol. 1991 Nov-Dec;142(6):423-38.

PMID:
1803410
50.

Lethal neurotoxicity in mice of the basic domains of HIV and SIV Rev proteins. Study of these regions by circular dichroism.

Mabrouk K, Van Rietschoten J, Vives E, Darbon H, Rochat H, Sabatier JM.

FEBS Lett. 1991 Sep 2;289(1):13-7.

Supplemental Content

Loading ...
Support Center